insitro has completed what it says is the first population-scale [...]

Sweden-based Nanexa has reported preclinical data for a long-acting semaglutide [...]

CORXEL has completed a Series D1 financing of up to [...]

The UK’s General Pharmaceutical Council (GPhC) has formally recognised Oushk [...]

The 7th UAE Obesity Conference brought together international experts in [...]

Nanexa says its long-acting subcutaneous technology could reduce the dosing [...]

Skye Bioscience has reported topline results from its Phase 2a [...]